Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: High expression of HNRNPR in ESCA combined with 18F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA

Fig. 2

The relationship between the HNRNPR expression and clinicopathological parameters in ESCA patients. A Kaplan–Meier graph showing the survival analyses of ESCA patients based on HNRNPR expression. B ROC curve analysis of HNRNPR diagnosis in ESCA. The HNRNPR mRNA expression level was expressed in C histological type, D weight, E Body mass index (BMI), F reflux history, G smoking, and H alcohol consumption. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page